SNYDER DAVID S — SEC Form 4 filings

SEC reporting owner CIK 1398625. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-26.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-02 to 2026-01-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Coya Therapeutics, Inc. (COYA)Chief Financial Officer51 leg · 1,800 sh · $12,9344

Form 4 filings — SNYDER DAVID S

FiledFormIssuerReported transactionsSource
2026-01-264Coya Therapeutics, Inc. (COYA)Grant/award (A): 140,041 (derivative) @ $0EDGAR
2025-01-134Coya Therapeutics, Inc. (COYA)Grant/award (A): 140,562 (derivative) @ $0EDGAR
2024-11-144Coya Therapeutics, Inc. (COYA)Purchase (P): 1,800 @ $7.19EDGAR
2024-06-054Coya Therapeutics, Inc. (COYA)Grant/award (A): 70,596 (derivative) @ $0EDGAR
2024-02-024Coya Therapeutics, Inc. (COYA)Grant/award (A): 81,819 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1398625 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →